{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:22:26Z","timestamp":1777418546344,"version":"3.51.4"},"reference-count":104,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[1994,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To update readers on the clinical management of infections caused by Mycobacterium tuberculosis, to provide a general description of the organism, culture and susceptibility testing, and clinical manifestations of the disease, and to provide several aspects of the treatment of the disease, including historical perspective, current approaches, and research opportunities for the future.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>The current medical literature, including abstracts presented at recent international meetings, is reviewed. References were identified through MEDLINE, MEDLARS II, Current Contents, and published meeting abstracts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY SELECTION:<\/jats:title>\n                    <jats:p>Data regarding the epidemiology, clinical manifestations, culture and susceptibility testing, and treatment of tuberculosis are cited. Specific attention has been focused on the clinical management of patients with noncontagious infection and potentially contagious active disease (TB) caused by M. tuberculosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA EXTRACTION:<\/jats:title>\n                    <jats:p>Information contributing to the discussion of the topics selected by the authors is reviewed. Data supporting and disputing specific conclusions are presented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SYNTHESIS:<\/jats:title>\n                    <jats:p>The incidence of TB is increasing in the US, despite the fact that available technologies are capable of controlling the vast majority of existing cases. Fueling the fire is the problem of coinfection with HIV and M. tuberculosis. Very few drugs are available for the treatment of TB, and few of these approach the potency of isoniazid and rifampin. Preventive therapy of patients exposed to multiple-drug\u2014resistant M. tuberculosis (MDR-TB) is controversial and of unknown efficacy. Treatment of active disease caused by MDR-TB requires up to four times longer, is associated with increased toxicity, and is far less successful than the treatment of drug-susceptible TB. Strategies for the management of such cases are presented. The rising incidence of TB in the US reflects a breakdown in the healthcare systems responsible for controlling the disease, which reflects the past budgetary reductions. Although TB control is one of the most cost-effective public health strategies, funding has been cut repeatedly despite the fact that TB was never eliminated. This has helped to produce the current crisis, including the spread of MDR-TB in many urban areas. The elimination of TB will now take decades longer, cost hundreds of millions of dollars more, and result in vastly higher morbidity and mortality rates than would have occurred with timely, adequate measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Tremendous effort and far more funding will be required to eliminate TB in the US. The selection of drug therapy must be based on the susceptibility data for each isolate. Multipledrug therapy must be continued for 6 to \u2a7e24 months, and patient adherence to prescribed regimens must be verified in all cases of TB. Significant antimycobacterial drug malabsorption has been documented in AIDS patients with TB, and may result in treatment failure. New agents are needed to improve the clinical outcome in patients with MDR-TB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/106002809402800115","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T14:59:11Z","timestamp":1484319551000},"page":"72-84","source":"Crossref","is-referenced-by-count":20,"title":["Infection Caused by\n                    <i>Mycobacterium Tuberculosis<\/i>"],"prefix":"10.1177","volume":"28","author":[{"given":"Charles A.","family":"Peloquin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun E.","family":"Berning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1994,1,1]]},"reference":[{"issue":"3","key":"bibr-bibr1-106002809402800115","first-page":"1","volume":"38","author":"Centers for Disease Control","year":"1989","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr-bibr2-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.3.725"},{"key":"bibr-bibr3-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.6.1623"},{"key":"bibr-bibr4-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500020017003"},{"key":"bibr-bibr5-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.4.741"},{"key":"bibr-bibr6-106002809402800115","unstructured":"Grange JM. Mycobacteria and human disease. London: Edward Amold, 1988: 1\u20138."},{"key":"bibr-bibr7-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-0305-3_1"},{"key":"bibr-bibr8-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1126\/science.257.5073.1055"},{"key":"bibr-bibr9-106002809402800115","unstructured":"Des Prez RM, Heim CR.\n                      Mycobacterium tuberculosis.\n                      In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1990: 1877\u2013906."},{"key":"bibr-bibr10-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/16.2.219"},{"key":"bibr-bibr11-106002809402800115","first-page":"169","volume":"38","author":"Snider DE","year":"1993","journal-title":"Adv Intern Med"},{"key":"bibr-bibr12-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/jhmas\/45.3.366"},{"key":"bibr-bibr13-106002809402800115","first-page":"1","volume":"20","author":"Styblo K","year":"1980","journal-title":"Adv Tuberc Res"},{"key":"bibr-bibr14-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199301001-00025"},{"key":"bibr-bibr15-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490120095035"},{"key":"bibr-bibr16-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106063242307"},{"key":"bibr-bibr17-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/136.2.492"},{"key":"bibr-bibr18-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.1.191"},{"key":"bibr-bibr19-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.4.745"},{"key":"bibr-bibr20-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302253280802"},{"key":"bibr-bibr21-106002809402800115","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-3-184"},{"key":"bibr-bibr22-106002809402800115","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-3-257"},{"key":"bibr-bibr23-106002809402800115","first-page":"355","volume":"134","author":"American Thoracic Society\/Centers for Disease Control","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"bibr-bibr24-106002809402800115","first-page":"61","volume":"41","author":"Centers for Disease Control","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr-bibr25-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_2.S471"},{"key":"bibr-bibr26-106002809402800115","first-page":"89","volume-title":"Drug susceptibility in the chemotherapy of mycobacterial infections","author":"Heifets LB","year":"1991"},{"key":"bibr-bibr27-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-199304000-00016"},{"key":"bibr-bibr28-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1097\/00001432-199304000-00007"},{"key":"bibr-bibr29-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.28.9.2094-2098.1990"},{"key":"bibr-bibr30-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.10.4.506-514.1979"},{"key":"bibr-bibr31-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1126\/science.8484123"},{"key":"bibr-bibr32-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.6.1348"},{"key":"bibr-bibr33-106002809402800115","first-page":"13","volume-title":"Drug susceptibility in the chemotherapy of mycobacterial infections","author":"Heifets LB","year":"1991"},{"issue":"1","key":"bibr-bibr34-106002809402800115","first-page":"11","volume":"3","author":"Verbist L","year":"1974","journal-title":"Medicon Int"},{"issue":"3","key":"bibr-bibr35-106002809402800115","first-page":"3","volume":"3","author":"Verbist L","year":"1974","journal-title":"Medicon Int"},{"key":"bibr-bibr36-106002809402800115","first-page":"353","volume-title":"The biology of mycobacteria","volume":"1","author":"Winder FG","year":"1982"},{"key":"bibr-bibr37-106002809402800115","first-page":"59","volume-title":"Drug susceptibility in the chemotherapy of mycobacterial infections","author":"Peloquin CA","year":"1991"},{"key":"bibr-bibr38-106002809402800115","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198814020-00002"},{"key":"bibr-bibr39-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1177\/106002808902301010"},{"key":"bibr-bibr40-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.3.399"},{"key":"bibr-bibr41-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390100083020"},{"key":"bibr-bibr42-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.3.483"},{"key":"bibr-bibr43-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_2.S467"},{"key":"bibr-bibr44-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/146.6.1445"},{"key":"bibr-bibr45-106002809402800115","unstructured":"Madsen L, Berning S, Iseman M, Peloquin C. Tolerance of fluoroquinolones in the treatment of mycobacterial infections (abstract H11). 1993 American Lung Association American Thoracic Society Conference, May 16\u201319, 1993, San Francisco, CA."},{"key":"bibr-bibr46-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90066-S"},{"key":"bibr-bibr47-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.3.542"},{"key":"bibr-bibr48-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(87)90053-5"},{"key":"bibr-bibr49-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/137.3.719"},{"key":"bibr-bibr50-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/0962-8479(92)90081-T"},{"key":"bibr-bibr51-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1237"},{"key":"bibr-bibr52-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.2.183"},{"key":"bibr-bibr53-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(91)90002-W"},{"key":"bibr-bibr54-106002809402800115","first-page":"147","volume-title":"Drug susceptibility in the chemotherapy of mycobacterial infections","author":"Cynamon MH","year":"1991"},{"key":"bibr-bibr55-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.1947"},{"key":"bibr-bibr56-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.10.1953"},{"key":"bibr-bibr57-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_2.S479"},{"key":"bibr-bibr58-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.5.675"},{"key":"bibr-bibr59-106002809402800115","doi-asserted-by":"publisher","DOI":"10.3109\/10611869308998758"},{"key":"bibr-bibr60-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_2.S420"},{"key":"bibr-bibr61-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(91)90038-T"},{"key":"bibr-bibr62-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.6.967"},{"key":"bibr-bibr63-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(86)90002-4"},{"key":"bibr-bibr64-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.1.143"},{"key":"bibr-bibr65-106002809402800115","first-page":"55","volume-title":"Tuberculosis","author":"Comstock GW","year":"1986","edition":"2"},{"key":"bibr-bibr66-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/143.3.490"},{"key":"bibr-bibr67-106002809402800115","first-page":"663","volume":"37","author":"Centers for Disease Control","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr-bibr68-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_2.S379"},{"key":"bibr-bibr69-106002809402800115","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-3-251"},{"key":"bibr-bibr70-106002809402800115","first-page":"573","volume":"111","author":"Comstock GW","year":"1975","journal-title":"Am Rev Respir Med"},{"key":"bibr-bibr71-106002809402800115","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-6-817"},{"key":"bibr-bibr72-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/137.1.2"},{"key":"bibr-bibr73-106002809402800115","first-page":"220","volume":"1","author":"Goble M","year":"1986","journal-title":"Semin Respir Infect"},{"key":"bibr-bibr74-106002809402800115","first-page":"253","volume":"33","author":"Iseman MD","year":"1988","journal-title":"Adv Intern Med"},{"key":"bibr-bibr75-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(21)00637-7"},{"key":"bibr-bibr76-106002809402800115","volume-title":"The tubercle bacillus in the pulmonary lesion of man; histobacteriology and its bearing on the therapy of pulmonary tuberculosis","author":"Canetti G","year":"1955"},{"key":"bibr-bibr77-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510010071032"},{"key":"bibr-bibr78-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1012737"},{"key":"bibr-bibr79-106002809402800115","first-page":"325","volume":"111","author":"Fox W","year":"1975","journal-title":"Am Rev Respir Dis"},{"key":"bibr-bibr80-106002809402800115","first-page":"977","volume":"5","author":"Stratton MA","year":"1986","journal-title":"Clin Pharm"},{"key":"bibr-bibr81-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1012738"},{"key":"bibr-bibr82-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199101313240503"},{"issue":"7","key":"bibr-bibr83-106002809402800115","first-page":"1","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr-bibr84-106002809402800115","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198223010-00003"},{"key":"bibr-bibr85-106002809402800115","first-page":"664","volume":"10","author":"Peloquin CA","year":"1991","journal-title":"Clin Pharm"},{"key":"bibr-bibr86-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30191-2"},{"key":"bibr-bibr87-106002809402800115","volume-title":"AHFS Drug Information 93","author":"McEvoy GK","year":"1993"},{"key":"bibr-bibr88-106002809402800115","volume-title":"The use of antiobiotics","author":"Kucers A","year":"1987","edition":"4"},{"key":"bibr-bibr89-106002809402800115","first-page":"31","volume":"22","author":"Peloquin CA","year":"1992","journal-title":"Drug Therapy"},{"key":"bibr-bibr90-106002809402800115","unstructured":"Gordon S, Horsburgh R, Havlik J, Heifets L, Peloquin C, Metchock B, Impaired absorption of oral regimen in treatment of disseminated\n                      M. avium\n                      complex infection (abstract 896). 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA October 1992."},{"key":"bibr-bibr91-106002809402800115","author":"Gordon SM","journal-title":"J Infect Dis"},{"key":"bibr-bibr92-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212173272514"},{"key":"bibr-bibr93-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310073291513"},{"key":"bibr-bibr94-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1378\/chest.76.6_Supplement.750"},{"key":"bibr-bibr95-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/147.5.1311"},{"key":"bibr-bibr96-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302253280811"},{"key":"bibr-bibr97-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(21)00641-9"},{"key":"bibr-bibr98-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199011000-00002"},{"key":"bibr-bibr99-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1542\/peds.89.1.161"},{"key":"bibr-bibr100-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(21)01136-9"},{"key":"bibr-bibr101-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1378\/chest.101.4.1114"},{"key":"bibr-bibr102-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1177\/106002809002400918"},{"key":"bibr-bibr103-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700606"},{"key":"bibr-bibr104-106002809402800115","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302701233"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809402800115","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/106002809402800115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:07:29Z","timestamp":1777374449000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/106002809402800115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["10.1177\/106002809402800115"],"URL":"https:\/\/doi.org\/10.1177\/106002809402800115","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}